GlomCon Europe 2027

Building on the success of its inaugural year, GlomCon Europe returns in 2027 for its second annual gathering, continuing its commitment to advancing global collaboration in glomerular disease education and research.

Join us April 19–21, 2027, at the Hilton Budapest Hotel in Budapest, Hungary, for a three-day hybrid event bringing together nephrologists, pathologists, researchers, and educators from around the world. Through expert-led educational sessions, scientific presentations, and meaningful opportunities for collaboration, GlomCon Europe will continue to strengthen our global community and advance the understanding and care of glomerular disease.

Why GlomCon Europe?

GlomCon’s mission is to deliver world-class nephrology education grounded in evidence and free from commercial or ideological bias.

GlomCon Europe is more than a conference - it is a global gathering of expertise, ideas, and shared purpose. In 2026, we welcomed more than 240 in-person and virtual attendees from 47 countries, bringing together 36 distinguished faculty and speakers for 23 educational sessions and 29 oral abstract presentations.

As the landscape of kidney care continues to evolve, international collaboration and the exchange of knowledge are more important than ever. GlomCon Europe provides a platform for nephrologists, pathologists, and researchers from around the world to share perspectives, explore emerging evidence, and advance the future of glomerular disease care.

From April 19-21, 2027, we invite you to join us at the Hilton Budapest Hotel for three days of world-class education, meaningful scientific exchange, and opportunities to build lasting international partnerships.

Together, we will advance knowledge, strengthen our global community, and help shape a more connected, innovative, and patient-centered future in glomerular disease care.

Satellite Symposia

Four industry-sponsored satellite symposia are integrated across both days to offer additional learning opportunities on the latest in clinical trials and therapeutic strategies in glomerular diseases.